Eiji Kashiyama

Antitumor Benzothiazoles. 8. Synthesis, Metabolic Formation, and Biological Properties of the <i>C</i>- and <i>N</i>-Oxidation Products of Antitumor 2-(4-Aminophenyl)benzothiazoles

Eiji Kashiyama, Ian Hutchinson, Mei‐Sze Chua et al. · Journal of Medicinal Chemistry · 1999 · 225 citations

Role of Cyp1A1 in modulation of antitumor properties of the novel agent 2-(4-amino-3-methylphenyl)benzothiazole (DF 203, NSC 674495) in human breast cancer cells.

Mei‐Sze Chua, Eiji Kashiyama, Tracey D. Bradshaw et al. · PubMed · 2000 · 102 citations

Medicinal Chemistry, Antitumor Properties, Breast Oncology +13

High performance liquid chromatographic methods for the determination of aripiprazole with ultraviolet detection in rat plasma and brain: Application to the pharmacokinetic study

Yoshihiko Shimokawa, Hitoshi Akiyama, Eiji Kashiyama et al. · Journal of Chromatography B · 2005 · 74 citations

Pharmacological Study, Medicine, Pharmacokinetic Study +8

In Vitro P-Glycoprotein Interactions and Steady-State Pharmacokinetic Interactions Between Tolvaptan and Digoxin in Healthy Subjects

Susan E. Shoaf, Yoshihiro Ohzone, Shinichi Ninomiya et al. · The Journal of Clinical Pharmacology · 2010 · 47 citations

Two Novel CYP2D6*10 Haplotypes As Possible Causes of a Poor Metabolic Phenotype in Japanese

Masayuki Matsunaga, Hiroshi Yamazaki, Kazuma Kiyotani et al. · Drug Metabolism and Disposition · 2009 · 32 citations